Access this stock data via API
Subscribe
Astellas Pharma Inc.
0
0
0%

Financials

Income statement

Fiscal date Jun 2025 Jun 2024 Mar 2024 Dec 2023
Total reported revenue 414.6B 421.9B
Cost of revenue 73.2B 75.9B
Gross profit 341.4B 346.0B
Operating expense
Research & development 77.9B 74.4B
Selling general and admin 193.1B 199.5B
Other operating expenses 83.8B 23.4B
Operating income -45.9B 18.9B
Non operating interest income
Income 4.1B 1.2B
Expense 4.2B 2.8B
Other income expense
Pretax income -48.7B 17.3B
Tax provision -15.4B 2.8B
Net income -33.3B 14.5B
Basic EPS 38.2 21 8.1
Diluted EPS 38.1 20.9 8.1
Basic average shares 1.8B 1.8B 1.8B
Diluted average shares 1.8B 1.8B 1.8B
EBITDA 4.2B 66.8B
Net income from continuing op. -48.7B 21.5B
Minority interests
Preferred stock dividends 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 12 hours 56 minutes

20:03
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 15:30
All times are displayed in the Asia/Tokyo timezone (JST, UTC+09:00).